Cargando…

Mutations in spliceosomal proteins and retina degeneration

A majority of human genes contain non-coding intervening sequences – introns that must be precisely excised from the pre-mRNA molecule. This event requires the coordinated action of five major small nuclear ribonucleoprotein particles (snRNPs) along with additional non-snRNP splicing proteins. Intro...

Descripción completa

Detalles Bibliográficos
Autores principales: Růžičková, Šárka, Staněk, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449078/
https://www.ncbi.nlm.nih.gov/pubmed/27302685
http://dx.doi.org/10.1080/15476286.2016.1191735
_version_ 1783239703281008640
author Růžičková, Šárka
Staněk, David
author_facet Růžičková, Šárka
Staněk, David
author_sort Růžičková, Šárka
collection PubMed
description A majority of human genes contain non-coding intervening sequences – introns that must be precisely excised from the pre-mRNA molecule. This event requires the coordinated action of five major small nuclear ribonucleoprotein particles (snRNPs) along with additional non-snRNP splicing proteins. Introns must be removed with nucleotidal precision, since even a single nucleotide mistake would result in a reading frame shift and production of a non-functional protein. Numerous human inherited diseases are caused by mutations that affect splicing, including mutations in proteins which are directly involved in splicing catalysis. One of the most common hereditary diseases associated with mutations in core splicing proteins is retinitis pigmentosa (RP). So far, mutations in more than 70 genes have been connected to RP. While the majority of mutated genes are expressed specifically in the retina, eight target genes encode for ubiquitous core snRNP proteins (Prpf3, Prpf4, Prpf6, Prpf8, Prpf31, and SNRNP200/Brr2) and splicing factors (RP9 and DHX38). Why mutations in spliceosomal proteins, which are essential in nearly every cell in the body, causes a disease that displays such a tissue-specific phenotype is currently a mystery. In this review, we recapitulate snRNP functions, summarize the missense mutations which are found in spliceosomal proteins as well as their impact on protein functions and discuss specific models which may explain why the retina is sensitive to these mutations.
format Online
Article
Text
id pubmed-5449078
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-54490782017-06-08 Mutations in spliceosomal proteins and retina degeneration Růžičková, Šárka Staněk, David RNA Biol Review A majority of human genes contain non-coding intervening sequences – introns that must be precisely excised from the pre-mRNA molecule. This event requires the coordinated action of five major small nuclear ribonucleoprotein particles (snRNPs) along with additional non-snRNP splicing proteins. Introns must be removed with nucleotidal precision, since even a single nucleotide mistake would result in a reading frame shift and production of a non-functional protein. Numerous human inherited diseases are caused by mutations that affect splicing, including mutations in proteins which are directly involved in splicing catalysis. One of the most common hereditary diseases associated with mutations in core splicing proteins is retinitis pigmentosa (RP). So far, mutations in more than 70 genes have been connected to RP. While the majority of mutated genes are expressed specifically in the retina, eight target genes encode for ubiquitous core snRNP proteins (Prpf3, Prpf4, Prpf6, Prpf8, Prpf31, and SNRNP200/Brr2) and splicing factors (RP9 and DHX38). Why mutations in spliceosomal proteins, which are essential in nearly every cell in the body, causes a disease that displays such a tissue-specific phenotype is currently a mystery. In this review, we recapitulate snRNP functions, summarize the missense mutations which are found in spliceosomal proteins as well as their impact on protein functions and discuss specific models which may explain why the retina is sensitive to these mutations. Taylor & Francis 2016-06-14 /pmc/articles/PMC5449078/ /pubmed/27302685 http://dx.doi.org/10.1080/15476286.2016.1191735 Text en © 2017 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Review
Růžičková, Šárka
Staněk, David
Mutations in spliceosomal proteins and retina degeneration
title Mutations in spliceosomal proteins and retina degeneration
title_full Mutations in spliceosomal proteins and retina degeneration
title_fullStr Mutations in spliceosomal proteins and retina degeneration
title_full_unstemmed Mutations in spliceosomal proteins and retina degeneration
title_short Mutations in spliceosomal proteins and retina degeneration
title_sort mutations in spliceosomal proteins and retina degeneration
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449078/
https://www.ncbi.nlm.nih.gov/pubmed/27302685
http://dx.doi.org/10.1080/15476286.2016.1191735
work_keys_str_mv AT ruzickovasarka mutationsinspliceosomalproteinsandretinadegeneration
AT stanekdavid mutationsinspliceosomalproteinsandretinadegeneration